Home/Filings/4/0001209191-21-036326
4//SEC Filing

Castellanos Elaine 4

Accession 0001209191-21-036326

CIK 0001358762other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 6:15 PM ET

Size

18.1 KB

Accession

0001209191-21-036326

Insider Transaction Report

Form 4
Period: 2021-05-26
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-267,06619,934 total
    Exercise: $22.57Exp: 2026-12-07Class B common stock (7,066 underlying)
  • Conversion

    Class B common stock

    2021-05-2610,0000 total
    Class A common stock (10,000 underlying)
  • Sale

    Class A common stock

    2021-05-26$124.55/sh10,000$1,245,47014,546 total
  • Conversion

    Class A common stock

    2021-05-26+10,00024,546 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-262,9340 total
    Exercise: $11.00Exp: 2026-05-25Class B common stock (2,934 underlying)
  • Exercise/Conversion

    Class B common stock

    2021-05-26$11.00/sh+2,934$32,2742,934 total
    Class A common stock (2,934 underlying)
  • Exercise/Conversion

    Class B common stock

    2021-05-26$22.57/sh+7,066$159,48010,000 total
    Class A common stock (7,066 underlying)
Footnotes (4)
  • [F1]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $124.36 to $124.95. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The options vested in sixteen equal quarterly installments beginning on August 25, 2016.
  • [F4]The options vest in twenty equal quarterly installments beginning on March 7, 2017, subject to continued service through each vesting date.

Issuer

REATA PHARMACEUTICALS INC

CIK 0001358762

Entity typeother

Related Parties

1
  • filerCIK 0001662520

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:15 PM ET
Size
18.1 KB